Recent clinical evidence from 2024 consistently identifies resistance training as the most effective exercise intervention for sarcopenia, the progressive loss of muscle mass and strength affecting older adults. Multicomponent programs combining resistance work with aerobic exercise and balance training deliver superior clinical outcomes compared to single-modality approaches. This represents a significant evolution in sarcopenia management, particularly given the absence of approved pharmaceutical treatments for this condition that affects up to 50% of adults over 80. The emergence of technology-assisted and home-based delivery methods addresses longstanding barriers to exercise adherence in older populations, potentially democratizing access to effective interventions. However, the field remains hampered by inconsistent diagnostic criteria and underpowered studies, limiting clinical translation. While resistance training's primacy is now well-established, the optimal dosing parameters—frequency, intensity, and progression schemes—require further refinement. This convergence of evidence arrives at a critical juncture as healthcare systems grapple with aging populations and rising sarcopenia prevalence, positioning structured resistance programs as both preventive and therapeutic interventions for maintaining functional independence in later life.